US$ 21.31
gip/glp-1 drugs The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP-1 Medications for Weight Loss:
Description
Li J, Liu X, Fang Q, Ding M, Li C

Some patients may need to wait for generic GLP-1 medications, which eventually will arrive on the scene

In PCOS-related trials, even with low starting doses and gradual titration, discontinuation rates of approximately 5%15% are frequently observed (125, 128)

C., Edmondson, S., Feeney, W

GLP-1R Agonist Exendin-4 Protects Against Hemorrhagic Transformation Induced by rtPA After Ischemic Stroke via the Wnt/beta-Catenin Signaling Pathway
